FAM
ITCI

Fred Alger Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Fred Alger Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,564
Closed -$1.13M – 485
2024
Q2 		$1.13M Buy
16,564
+4,030
+32% +$280K 0.01% 353
2024
Q1 		$867K Buy
+12,534
New +$861K ﹤0.01% 376
2022
Q4 		– Sell
-38,536
Closed -$1.79M – 576
2022
Q3 		$1.79M Sell
38,536
-46,184
-55% -$2.41M 0.01% 350
2022
Q2 		$4.84M Sell
84,720
-21,008
-20% -$1.19M 0.02% 267
2022
Q1 		$6.47M Buy
+105,728
New +$5.49M 0.02% 250
2017
Q4 		– Sell
-20,000
Closed -$316K – 598
2017
Q3 		$316K Buy
20,000
+7,000
+54% +$103K ﹤0.01% 371
2017
Q2 		$161K Buy
+13,000
New +$151K ﹤0.01% 393
2016
Q3 		– Sell
-5,200
Closed -$202K – 541
2016
Q2 		$202K Buy
+5,200
New +$187K ﹤0.01% 415
2015
Q4 		– Sell
-6,700
Closed -$268K – 596
2015
Q3 		$268K Sell
6,700
-25,750
-79% -$840K ﹤0.01% 460
2015
Q2 		$1.04M Sell
32,450
-132,347
-80% -$3.36M ﹤0.01% 425
2015
Q1 		$3.94M Buy
+164,797
New +$3.69M 0.02% 367

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fred Alger Management's ITCI Position: Q3 2024 in Review

Fred Alger Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q3 2024, closing a stake of 16,564 shares — an estimated $1.13M sold.

Fred Alger Management first reported a position in ITCI in Q1 2015 and held it in 11 quarters. The position peaked at $6.47M in Q1 2022. 354 funds tracked by Wall St. Rank hold ITCI as of Q3 2024.

  • Fred Alger Management reported no remaining Intra-Cellular Therapies Inc. position as of Q3 2024 after selling out during the quarter.
  • Fred Alger Management sold 16,564 Intra-Cellular Therapies Inc. shares in Q3 2024, an estimated $1.13M.
  • Fred Alger Management first reported a position in Intra-Cellular Therapies Inc. in Q1 2015 and held it in 11 quarters.
  • Fred Alger Management's Intra-Cellular Therapies Inc. position peaked at $6.47M in Q1 2022.
  • 354 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2024.

Based on Fred Alger Management's 13F filing for Q3 2024, filed 14 Nov 2024.